The largest database of trusted experimental protocols

Anti phospho igf 1rβ

Manufactured by Cell Signaling Technology
Sourced in United States

Anti-phospho IGF-1Rβ is a laboratory reagent that specifically detects the phosphorylated form of the insulin-like growth factor 1 receptor beta subunit (IGF-1Rβ). It is used to monitor the activation status of the IGF-1 signaling pathway in biological samples.

Automatically generated - may contain errors

4 protocols using anti phospho igf 1rβ

1

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein extraction and western blot analysis was performed as previously described [14 (link), 20 (link)]. The following antibodies were used: anti-phospho IGF-1Rβ(Tyr1135/1136)/Insulin Receptorβ(Tyr1150/1151), anti-total Insulin Receptorβ and total IGF-1Rβ (Cell Signaling Technology, Danvers, MA, USA) and anti-β-actin (Sigma Aldrich, St Louis, MO, USA) at concentrations detailed in electronic supplementary material (ESM) Table 1. Western blots were imaged and quantified by densitometry after incubation with LI-COR IRdye secondary antibodies with a LI-COR scanner and LI-COR Image Studio software (LI-COR, Lincoln, NE, USA).
+ Open protocol
+ Expand
2

Antibody Sourcing and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-NDRG1 antibody was generated as previously described [43 (link)]. Other antibodies were purchased as follows: anti-α-tubulin antibody was from Sigma-aldrich Co; anti-EGFR, anti-phospho-EGFR (Tyr1068), anti-phospho-HER3, anti-Met, anti-phospho-Met, anti-PDGFRβ, anti-phospho-PDGFRβ, anti- IGF-1Rβ, anti-phospho-IGF-1Rβ, anti-ERK1/2, anti-phospho-ERK1/2, anti-AKT, anti-phospho-AKT (Thr308 and Ser473), anti-mTOR, anti-phospho-mTOR (Ser2448 and Ser2481), anti-Raptor, anti-Rictor, anti-S6K, anti-phospho-S6K(Thr389), anti-phospho-S6, anti-PTEN, anti-phospho-PTEN, anti-IRS-1, anti-PDK1, anti-PARP, anti-phospho-PDK1, anti-TSC-1, anti-TSC-2, and anti-phospho-4EBP-1 antibodies were from Cell Signaling Technology (Beverly, MA); anti-HER2 and anti-HER3 antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA); anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody was from Trevigen Inc. (Gaithersburg, MD): anti-p27 antibody was from BD Biosciences (San Jose, CA): anti-cleaved PARP antibody was from Promega (Madison, WI): anti-phospho-HER2 antibody was from Millipore (Billerica, MA): anti-β-actin was from Abcam (Cambridge, UK).
+ Open protocol
+ Expand
3

Pluripotency Marker Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary antibodies included anti-phospho-IGF1R-β (Tyr1135/1136)/INSR-β (Tyr1150/1151), phospho-AKT (Ser473), AKT, phospho-ERK1/2 (Thr202/Tyr204), ERK1/2, and phospho-GSK3α/β (Ser21/9) (Cell Signaling); INSR-β and IGF1R-β (Santa Cruz); GSK3α/β (Millipore); phospho-insulin receptor substrate 1 (IRS1) (Y612) (Life Technologies); IRS1 (BD Biosciences); NANOG and OCT4 (Abcam); and SSEA4 and TRA-1-60 (Millipore).
+ Open protocol
+ Expand
4

Targeted Inhibitor Screening in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PP242 (#CD0258), Ku-0063794 (#CD0274), and PX-866 (#CD0279) were from Chemdea (Ridgewood, NJ, USA). BKM-120 (#S2247), BYL719 (#S2814), MK-2206 (#S1078), NVP-AEW541 (#S1034), sapitinib (#S2192), and erlotinib (#S7786) were from Selleck Chemicals (Houston, TX, USA). Anti-phospho-AKT (#4060), anti-AKT (#2920), and anti phospho-IGF-1Rβ (#3024) antibodies were from Cell Signaling Technology (Danvers, MA, USA). Anti-β-Actin (#A2228) antibody was from Sigma-Aldrich (Buchs, Switzerland). supplemented with 10% FBS and 1% streptomycin/penicillin in a 5% CO2 atmosphere and at 37ºC.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!